Publicaciones etiquetadas con: Cuban Center of Molecular Immunology

Biocon to produce Cuban drug for Covid-19 patients in India.

 

 

 

 

 

Biocon, India’s largest biopharmaceutical company, highlighted on Wednesday the production of the drug Itolizumab, developed by the Cuban Center of Molecular Immunology to treat seriously ill Covid-19 patients.

Sigue leyendo

Categorías: Uncategorized | Etiquetas: , , , , , , , | Deja un comentario

A %d blogueros les gusta esto: